MedTrace Logo

Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

NCT02812082 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-09-14

No results posted yet for this study

Summary

The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.

Conditions

  • Allo-SCT Patients
  • Adult Allo-SCT Survivor

Interventions

OTHER

web-based patient education

BEHAVIORAL

questionnaire

Sponsors & Collaborators

Principal Investigators

  • Kara Mosesso, NP · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02812082 on ClinicalTrials.gov